Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	59729-37-2
Formula :	C₁₂H₁₃N₃O₃S
M.W :	279.31
SMILES Code :	O=[N+](C1=CN=C(COC2=CC=C(SC)C=C2)N1C)[O-]
Synonyms :	HOE 239; Fexinidazole Winthrop
MDL No. :	MFCD00866607
InChI Key :	MIWWSGDADVMLTG-UHFFFAOYSA-N
Pubchem ID :	68792

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H332-H335
Precautionary Statements:	P261-P280-P305+P351+P338

L. donovani axenic amastigotes	2.8 ± 0.1 μM	72h	Evaluate the in vitro activity of Fexinidazole against L. donovani axenic amastigotes, showing an EC50 of 2.8 ± 0.1 μM.	PMC3457684
L. donovani promastigotes	5.6 ± 0.2 μM	72h	Evaluate the in vitro activity of Fexinidazole against L. donovani promastigotes, showing an EC50 of 5.6 ± 0.2 μM.	PMC3457684
G. lamblia	0.01–25 µM	48 h	Evaluate the activity of Fexinidazole and its metabolites against Entamoeba histolytica HM1:IMSS strain, showing that Fexinidazole had an EC50 of 9.7 µM, while its metabolites (sulfoxide and sulfone) were more than 5-fold more active than the parent drug.	PMC10777846
E. histolytica trophozoites	0.01–25 µM	48 h	Evaluate the activity of Fexinidazole and its metabolites against Giardia lamblia WB strain, showing that Fexinidazole had an EC50 of 5.6 µM, while its metabolites (sulfoxide and sulfone) were more than 10-fold more active than the parent drug.	PMC10777846
Trypanosoma brucei gambiense STIB930	1.84 ± 1.13 μM	72 h	Evaluate in vitro trypanocidal activity against STIB930 strain, IC50 1.84 μM	PMC3232772
Trypanosoma brucei brucei BS221 (wild type)	2.38 ± 0.88 μM	72 h	Evaluate in vitro trypanocidal activity against BS221 strain, IC50 2.38 μM	PMC3232772
Trypanosoma brucei rhodesiense STIB900pent	2.71 ± 0.87 μM	72 h	Evaluate in vitro trypanocidal activity against pentamidine-resistant strain, IC50 2.71 μM	PMC3232772
Trypanosoma brucei rhodesiense STIB900mel	2.66 ± 0.57 μM	72 h	Evaluate in vitro trypanocidal activity against melarsoprol-resistant strain, IC50 2.66 μM	PMC3232772
Trypanosoma brucei rhodesiense STIB900 (wild type)	2.17 ± 0.29 μM	72 h	Evaluate in vitro trypanocidal activity against STIB900 strain, IC50 2.17 μM	PMC3232772

BALB/c mice	Mouse model of visceral leishmaniasis	Oral	200 mg/kg	Once daily for 5 days	Evaluate the efficacy of Fexinidazole in a mouse model of visceral leishmaniasis, showing that oral administration of 200 mg kg?1 once daily for 5 days suppressed infection by 98.4%.	PMC3457684
C57BL/6 mice	Giardia lamblia infection model	Oral gavage	10 mg/kg	Once daily for 3 days	Evaluate the efficacy of Fexinidazole and its metabolites in a mouse model of Giardia lamblia infection, showing that Fexinidazole and its metabolites significantly reduced the infection.	PMC10777846
Swiss mice	Mouse model infected with VL-10 or Colombiana strains of T. cruzi	Oral	300 mg/kg	Once daily for 20 days	To evaluate the therapeutic efficacy of Fexinidazole in T. cruzi-infected mice. The ELA assay demonstrated cure rates of ~71% and ~77% for VL-10 and Colombiana strains, respectively, showing superior efficacy compared to Benznidazole.	PMC10811605
NMRI mice	Acute T. b. rhodesiense infection model	Oral	100 mg/kg	Four consecutive days	Evaluate efficacy in acute infection model, 100 mg/kg/day orally for 4 days achieved 100% cure	PMC3232772
Mice	Mouse models infected with different Trypanosoma cruzi strains	Oral	50, 100, 200, 300 mg/kg	7 or 20 consecutive days	To evaluate the efficacy of Fexinidazole against different Trypanosoma cruzi strains, results showed that Fexinidazole effectively suppressed parasitemia and prevented death in infected animals, with high cure rates in both acute and chronic phases.	PMC3486905

{[proInfo.proName]}

CAS No.: 59729-37-2

{[proInfo.proName]}

CAS No.: 59729-37-2

Alternative Products

Product Details of Fexinidazole

Safety of Fexinidazole

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT02571062	Trypanosomiasis, African	PHASE1	COMPLETED	2025-06-15	Biotrial, Rennes, France
NCT02498782	Chagas Disease ... More >> Trypanosomiasis, South American South American Trypanosomiasis Disease, Chagas Less <<	Phase 2	Unknown	February 2016	Bolivia ... More >> Plataforma Atención Integral de Pacientes con Enfermedad de Chagas Recruiting Cochabamba, Bolivia Contact: Faustino Torrico, MD 59177411905 foxtorrico@yahoo.com Contact: Cristina Alonso, MD 59172211312 calonso@dndi.org Principal Investigator: Faustino Torrico, MD Plataforma de Atención Integral de Pacientes con Enfermedad de Chagas Recruiting Tarija, Bolivia Contact: Lourdes O Daza, MD 5916672252 lourdesortizd@yahoo.es Contact: Erika Ribeiro, Pharm D 59175969924 ecorreia@dndi.org Principal Investigator: Lourdes O Daza, MD Less <<
NCT01483170	Trypanosomiasis, African	Phase 1	Terminated(poor tolerability a... More >>t highest dose) Less <<	-	France ... More >> SGS Life Sciences Paris, France, 75015 Less <<
NCT02169557	Human African Trypanosomiasis ... More >>(HAT) Less <<	PHASE2\|PHASE3	COMPLETED	2017-04-25	Kinshasa, Congo, The Democrati... More >>c Republic of the Less <<
NCT02184689	Human African Trypanosomiasis ... More >>(HAT) Less <<	Phase 2 Phase 3	Unknown	July 2017	Congo, The Democratic Republic... More >> of the Kinshasa, Congo, The Democratic Republic of the Less <<
NCT01685827	Human African Trypanosomiasis ... More >>(HAT) Sleeping Sickness Less <<	Phase 2 Phase 3	Completed	-	Central African Republic ... More >> Batangafo Batangafo, Central African Republic Congo, The Democratic Republic of the Bagata Hospital Bagata, Bandundu, Congo, The Democratic Republic of the Congo Masi Manimba Hospital Masi Manimba, Bandundu - DRC, Congo Vanga Hospital Vanga, Bandundu - DRC, Congo HGR Mushie hospital Mushie, Bandundu, Congo CRT (Centre de Réference et de Traitement) Dipumba, Dipumba general hospital Mbuji Mayi, East Kasai, Congo HS Katanda hospital Katanda, Kasaï Oriental, Congo HGR ISANGI hospital Isangi, Province Orientale, Congo HGR (General Reference Hospital) Bandundu Bandundu, Congo Dingila Dingila, Congo Less <<
NCT03025789	Trypanosomiasis, African\|Sleep... More >>ing Sickness\|Trypanosomiasis; Gambian Less <<	PHASE3	COMPLETED	2021-02-01	Dipumba Hospital, Mbuji-Mayi, ... More >>Kasa? Oriental Province, Congo, The Democratic Republic of the\|Bagata Hospital, Bagata, Kwilu Province, Congo, The Democratic Republic of the\|Bandundu Hospital, Bandundu, Kwilu Province, Congo, The Democratic Republic of the\|Masi Manimba Hospital, Masi Manimba, Kwilu Province, Congo, The Democratic Republic of the\|Nkara Secondary Hospital, Nkara, Kwilu Province, Congo, The Democratic Republic of the\|Mushie Hospital, Mushie, Ma? Ndombe Province, Congo, The Democratic Republic of the\|Roi Baudouin Hospital, Kinshasa, Congo, The Democratic Republic of the\|Dubreka Hospital, Dubreka, Guinea Less <<
NCT01980199	Visceral Leishmaniasis	PHASE2	TERMINATED	2025-09-15	Doka Hospital, Doka, Gedaref, ... More >>Sudan Less <<
NCT03587766	Chagas' Disease (Chronic) Nos	Phase 2	Recruiting	December 2019	Spain ... More >> Hospital Clinic Recruiting Barcelona, Catalunia, Spain, 08036 Contact: Maria Jesús Pinazo, MD +34932275400 mariajesus.pinazo@isglobal.org Contact: Elizabeth de Jesus Posada, MD +34932275400 elizabeth.posada@isglobal.org Sub-Investigator: Irene Losada, MD Less <<
NCT01340157	PK in Healthy Volunteers	PHASE1	COMPLETED	2025-04-11	SGS Aster s.a.s., Paris, 75015... More >>, France Less <<
NCT00982904	Human African Trypanosomiasis	Phase 1	Completed	-	France ... More >> SGS Aster Paris, France, 75015 Less <<
NCT03974178	Trypanosomiasis, African\|Sleep... More >>ing Sickness\|Trypanosoma Brucei Rhodesiense; Infection Less <<	PHASE2\|PHASE3	COMPLETED	2022-10-12	Rumphi District Hospital, Rump... More >>hi, PO Box 225, Malawi\|Lwala Hospital, Lwala, Kadeberamaido, PO Box 650, Uganda Less <<

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed